Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
F/m Emerald Life Sciences Innovation ETF (LFSC) belongs to the Life Sciences segment. Invesco DWA Healthcare Momentum ETF (PTH) is part of the US Health Care segment. LFSC's top 3 sector exposures are Health Care and Sovereign. In contrast, PTH's top sector exposures are Health Care LFSC is more expensive with a Total Expense Ratio (TER) of 0.79%, versus 0.72% for PTH. LFSC is down -3.7% year-to-date (YTD) with +$7M in YTD flows. PTH performs better with -0.94% YTD performance, and -$2M in YTD flows. Run a side-by-side ETF comparison of LFSC and PTH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | LFSC PTH | -2.09%+0.87% | -10.37%-2.99% | -3.70%-0.94% | +60.97%+31.67% | n/a+40.70% | n/a-4.17% |
| Flows | LFSC PTH | +$7M- | +$8M-$2M | +$7M-$2M | +$18M-$15M | --$92M | --$495M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | LFSC PTH | +22.01%+21.14% | +28.67%+24.53% | n/a+24.42% | n/a+25.61% |
| Max drawdown | LFSC PTH | -13.02%-7.58% | -19.03%-16.12% | n/a-29.24% | n/a-50.10% |
| Max drawdown duration | LFSC PTH | 90d86d | 70d183d | n/a271d | n/a1650d |
LFSC | PTH | |
Last sale 3/11/2026 at 1:30 PM | $35.01 | $48.86 |
| Previous close 03/10/2026 | $35.21 | $49.20 |
| Consolidated volume 03/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
LFSC | PTH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
LFSC | PTH | |
|---|---|---|
| Last price | $35.01 | $48.86 |
| 1D performance | -0.57% | -0.70% |
| AuM | $95.79 M | $122.13 M |
| E/R | 0.79% | 0.72% |
LFSC | PTH | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Emerald Group | Invesco |
| Benchmark | - | Dorsey Wright Healthcare Technical Leaders Index |
| N° of holdings | 34 | 46 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | October 31, 2024 | October 12, 2006 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
